Czechia vs France: Colon and rectum cancer screening coverage in Europe
Czechia
31.1%
in 2024
France
29.6%
in 2024
Czechia rank
14th
France rank
15th
Colon and rectum cancer screening coverage in Europe over time
- Czechia
- France
How they compare
Czechia currently reports 31.1% against 29.6% in France, a difference of 1.5%.
That makes Czechia's figure about 1.1 times France's.
The two have swapped places 3 times across 12 shared years of data; in 2011 it was France ahead.
Czechia ranks 14th and France ranks 15th of 20 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | France | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.2% | 27.3% | 0.9% | Czechia |
| 2020s | 28.8% | 28.7% | 0.0% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Czechia or France?
- Czechia, at 31.1% against 29.6% in France as of 2024.
- What is the difference in colon and rectum cancer screening coverage in europe between Czechia and France?
- 1.5%, with Czechia ahead.
- How many years of comparable data are there for Czechia and France?
- 12 years are reported by both, from 2011 to 2024.
- How do Czechia and France rank globally for colon and rectum cancer screening coverage in europe?
- Czechia ranks 14th and France ranks 15th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.